Dr. McCormack stated, “ABM is excited to offer this cutting-edge, brain-based assessment tool to better
identify ADHD. In the recent past doctors have relied upon relatively subjective data in their evaluation of ADHD symptoms.
Now with NEBA, a 15 to 20 minute test that integrates an EEG biomarker for ADHD into the traditional ADHD work-up, doctors
can utilize more objective data when considering a diagnosis of ADHD.”
Several issues underscore the importance of a thorough, objective
evaluation when assessing ADHD symptoms. One concern is that the percentage of US children aged 4 to 17 years old diagnosed
with ADHD continues to increase. In addition to the 42% increased rate of ADHD diagnosis between 2003-2011, the percentage
of children prescribed ADHD medications between 2007-2011 also increased by 28%. Furthermore, there are other conditions
commonly mistaken for ADHD, such as learning disabilities, hearing or vision problems, anxiety, depression, OCD, or bipolar
disorder. Further complicating the issue is the fact that ADHD commonly co-occurs alongside other psychiatric disorders.
Correctly differentiating between all of these
diagnostic possibilities requires more than symptom checklists. Without more objective testing such as NEBA, clinicians might
falsely attribute a patient's symptoms to ADHD, rather than another condition. This would not only delay appropriate intervention,
but also potentially expose the patient to unnecessary treatments with possible negative side effects. Using NEBA, doctors
can significantly reduce the number of patients receiving ADHD treatment as the initial focus when another condition would
potentially be the primary diagnosis. In the FDA validation study, NEBA reduced the potential for over-diagnosis from
34% to 3% and also provided confirmatory support for ADHD with an accuracy of 92%.
Patients or clinicians interested in obtaining
a NEBA evaluation should call (706) 316–1908 for further details. Because insurance coverage of NEBA varies widely
from plan to plan, our office does not file insurance claims for this service. The cost is $325, and we will be happy to provide
the patient with the appropriate codes and HCFA-1500 form if they would like to file a claim under their insurance policy
themselves. In order to make this valuable test more accessible to a large number of patients, NEBA Health offers a variety
of programs, including NEBA-Cares, to provide need-based assistance for those who qualify.